More about

Type 2 Diabetes

News
March 19, 2024
4 min read
Save

Once-weekly basal insulin noninferior to once-daily insulin for type 1, type 2 diabetes

Once-weekly basal insulin noninferior to once-daily insulin for type 1, type 2 diabetes

A once-weekly basal insulin conferred similar changes in HbA1c and time in range as once-daily insulin glargine among adults with type 1 and type 2 diabetes in three phase 2 trials, according to a speaker.

News
March 15, 2024
10 min read
Save

Greater access to obesity drugs puts spotlight on safety

Greater access to obesity drugs puts spotlight on safety

GLP-1 receptor agonists come with known adverse events — some common and some rare — but recent reports by the public of alopecia and suicidal ideation have the FDA investigating.

News
March 13, 2024
2 min read
Save

Top in endocrinology: FDA OKs OTC continuous glucose monitor; limited claims for yogurt

Top in endocrinology: FDA OKs OTC continuous glucose monitor; limited claims for yogurt

The FDA is allowing Dexcom Stelo to market and sell a continuous glucose monitor to patients without a prescription. The Dexcom Stelo Glucose Biosensor System will be the first over-the-counter CGM on the market.

News
March 08, 2024
3 min read
Save

Adults with type 2 diabetes see glycemic benefits with automated insulin delivery

Adults with type 2 diabetes see glycemic benefits with automated insulin delivery

Using a pod-based automated insulin delivery system can provide glycemic benefits for people with type 2 diabetes, according to a speaker at the International Conference on Advanced Technologies & Treatments for Diabetes.

News
March 08, 2024
4 min read
Save

Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care

Upcoming wave of hormone-based therapies set to change field of diabetes, obesity care

A slew of new medications currently in development may allow health care providers to go beyond glycemic management in the treatment of type 2 diabetes, according to a speaker.

News
March 05, 2024
1 min read
Save

FLOW: Semaglutide slows CKD progression, cuts risks for kidney, CV death in diabetes

FLOW: Semaglutide slows CKD progression, cuts risks for kidney, CV death in diabetes

Adults with type 2 diabetes and chronic kidney disease have a 24% lower risk for kidney disease progression and cardiovascular and kidney mortality with once-weekly semaglutide 1 mg, according to topline results from the FLOW trial.

News
March 05, 2024
4 min read
Save

Low birth weight plus overweight as young adults raises type 2 diabetes risk for men

Low birth weight plus overweight as young adults raises type 2 diabetes risk for men

Men who had a lower birth weight followed by overweight during young adulthood have a greatly increased risk for developing type 2 diabetes vs. those with normal weight at those times, according to study results published in Diabetologia.

News
March 04, 2024
3 min read
Save

FDA to allow limited claims that eating yogurt may reduce risk for type 2 diabetes

FDA to allow limited claims that eating yogurt may reduce risk for type 2 diabetes

The FDA said it will permit the use of two limited health claims that eating yogurt may reduce the risk for type 2 diabetes, according to a press release.

News
March 01, 2024
2 min read
Save

Testosterone therapy does not slow progression to diabetes, increase odds for remission

Testosterone therapy does not slow progression to diabetes, increase odds for remission

Testosterone replacement therapy alone did not lower risk for progression from prediabetes to diabetes or increase the likelihood of type 2 diabetes remission among men with hypogonadism, according to study data.

News
February 27, 2024
3 min read
Save

Bariatric surgery tied to larger HbA1c reduction than medical, lifestyle therapy

Bariatric surgery tied to larger HbA1c reduction than medical, lifestyle therapy

Adults with type 2 diabetes and obesity who underwent bariatric surgery were more likely to achieve diabetes remission at 7 years than those treated with medication or lifestyle intervention, according to study findings published in JAMA.

View more